Gene expression profiling of human gastrointestinal stromal tumors according to its malignant potential

Digestive Diseases and Sciences

Volumn 55, Issue 9, 2010, Pages 2561-2567

  Hur, Keun ^a   Lee, Hyuk Joon ^a   Woo, Jung Hoon ^b   Kim, Ju Han ^b   Yang, Han Kwang ^a  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

CDNA microarray; GISTs; Pathway enrichment analysis; SOM clustering

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CLINICAL ARTICLE; DNA MICROARRAY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956183484     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1061-4     Document Type: Article

References (20)

1. CD Fletcher JJ Berman C Corless F Gorstein J Lasota BJ Longley M Miettinen TJ O'Leary H Remotti BP Rubin B Shmookler LH Sobin SW Weiss 2002 Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol 33 459 465 10.1053/hupa.2002.123545 12094370 (Pubitemid 34747864)
2. LG Kindblom HE Remotti F Aldenborg JM Meis-Kindblom 1998 Gastrointestinal pacemaker cell tumor (gipact): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of cajal Am J Pathol 152 1259 1269 1:STN:280:DyaK1c3kvVejug%3D%3D 9588894
3. M Miettinen J Lasota 2001 Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis Virchows Arch 438 1 12 10.1007/s004280000338 1:CAS:528:DC%2BD3MXlt1Kquw%3D%3D 11213830 (Pubitemid 32128184)
4. CL Corless JA Fletcher MC Heinrich 2004 Biology of gastrointestinal stromal tumors J Clin Oncol 22 3813 3825 10.1200/JCO.2004.05.140 1:CAS:528:DC%2BD2cXhtVCitb%2FL 15365079 (Pubitemid 41095223)
5. BJ Druker M Talpaz DJ Resta B Peng E Buchdunger JM Ford NB Lydon H Kantarjian R Capdeville S Ohno-Jones CL Sawyers 2001 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 1037 10.1056/NEJM200104053441401 1:CAS:528: DC%2BD3MXivFGnu70%3D 11287972 (Pubitemid 32267972)
6. H Joensuu PJ Roberts M Sarlomo-Rikala LC Andersson P Tervahartiala D Tuveson S Silberman R Capdeville S Dimitrijevic B Druker GD Demetri 2001 Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 1052 1056 10.1056/ NEJM200104053441404 1:STN:280:DC%2BD3M3gvVekuw%3D%3D 11287975 (Pubitemid 32267975)
7. AT van Oosterom I Judson J Verweij S Stroobants E Donato di Paola S Dimitrijevic M Martens A Webb R Sciot M Van Glabbeke S Silberman OS Nielsen 2001 Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study Lancet 358 1421 1423 10.1016/S0140-6736(01)06535-7 11705489 (Pubitemid 33055745)
8. S Hirota K Isozaki Y Moriyama K Hashimoto T Nishida S Ishiguro K Kawano M Hanada A Kurata M Takeda G Muhammad Tunio Y Matsuzawa Y Kanakura Y Shinomura Y Kitamura 1998 Gain-of-function mutations of c-KIT in human gastrointestinal stromal tumors Science 279 577 580 10.1126/science.279.5350.577 1:CAS:528:DyaK1cXotVyhsw%3D%3D 9438854 (Pubitemid 28067289)
9. MC Heinrich CL Corless A Duensing L McGreevey CJ Chen N Joseph S Singer DJ Griffith A Haley A Town GD Demetri CD Fletcher JA Fletcher 2003 PDGFRA activating mutations in gastrointestinal stromal tumors Science 299 708 710 10.1126/science.1079666 1:CAS:528:DC%2BD3sXntFWitQ%3D%3D 12522257 (Pubitemid 36159485)
10. M Debiec-Rychter H Dumez I Judson B Wasag J Verweij M Brown S Dimitrijevic R Sciot M Stul H Vranck M Scurr A Hagemeijer M van Glabbeke AT van Oosterom 2004 Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 40 689 695 10.1016/j.ejca.2003.11.025 1:CAS:528: DC%2BD2cXhvVOrtL8%3D 15010069 (Pubitemid 38326618)
11. GD Demetri M von Mehren CD Blanke AD Van den Abbeele B Eisenberg PJ Roberts MC Heinrich DA Tuveson S Singer M Janicek JA Fletcher SG Silverman SL Silberman R Capdeville B Kiese B Peng S Dimitrijevic BJ Druker C Corless CD Fletcher H Joensuu 2002 Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 472 480 10.1056/NEJMoa020461 1:CAS:528:DC%2BD38XmtV2nt7s%3D 12181401 (Pubitemid 34879334)
12. J Verweij A van Oosterom JY Blay I Judson S Rodenhuis W van der Graaf J Radford A Le Cesne PC Hogendoorn ED di Paola M Brown OS Nielsen 2003 Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study Eur J Cancer 39 2006 2011 10.1016/S0959- 8049(02)00836-5 1:CAS:528:DC%2BD3sXmvVKgtrc%3D 12957454 (Pubitemid 37297756)
13. LL Chen JC Trent EF Wu GN Fuller L Ramdas W Zhang AK Raymond VG Prieto CO Oyedeji KK Hunt RE Pollock BW Feig KJ Hayes H Choi HA Macapinlac W Hittelman MA Velasco S Patel MA Burgess RS Benjamin ML Frazier 2004 A missense mutation in kit kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors Cancer Res 64 5913 5919 10.1158/0008-5472.CAN-04-0085 1:CAS:528:DC%2BD2cXntFClsr4%3D 15342366 (Pubitemid 39129383)
14. J Eberwine 1996 Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA Biotechniques 20 584 591 1:CAS:528:DyaK28XitFelsL0%3D 8800675
15. W Huber A von Heydebreck H Sultmann A Poustka M Vingron 2002 Variance stabilization applied to microarray data calibration and to the quantification of differential expression Bioinformatics 18 Suppl 1 S96 104 12169536
16. YH Yang S Dudoit P Luu, et al. 2002 Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucleic Acids Res 30 e15 10.1093/nar/30.4.e15 11842121
17. Kohonen T. Self-organizing maps. Berlin Heidelberg New York: Springer; 1995.
18. CR Antonescu A Viale L Sarran SJ Tschernyavsky M Gonen NH Segal RG Maki ND Socci RP DeMatteo P Besmer 2004 Gene expression in gastrointestinal stromal tumors is distinguished by kit genotype and anatomic site Clin Cancer Res 10 3282 3290 10.1158/1078-0432.CCR-03-0715 1:CAS:528:DC%2BD2cXkt1Ghs70%3D 15161681 (Pubitemid 38685432)
19. S Subramanian RB West CL Corless W Ou BP Rubin KM Chu SY Leung ST Yuen S Zhu T Hernandez-Boussard K Montgomery TO Nielsen RM Patel JR Goldblum MC Heinrich JA Fletcher M van de Rijn 2004 Gastrointestinal stromal tumors (GISTs) with kit and PDGFRA mutations have distinct gene expression profiles Oncogene 23 7780 7790 10.1038/sj.onc.1208056 1:CAS:528:DC%2BD2cXotl2ktbw%3D 15326474 (Pubitemid 39457028)
20. TO Nielsen RB West SC Linn O Alter MA Knowling JX O'Connell S Zhu M Fero G Sherlock JR Pollack PO Brown D Botstein M van de Rijn 2002 Molecular characterisation of soft tissue tumours: a gene expression study Lancet 359 1301 1307 10.1016/S0140-6736(02)08270-3 1:CAS:528:DC%2BD38XivVShs74%3D 11965276 (Pubitemid 34310636)